HomeInsightsStock Comparison

Ajanta Pharma Ltd vs Unichem Laboratories Ltd Stock Comparison

Ajanta Pharma Ltd vs Unichem Laboratories Ltd Stock Comparison

Last Updated on: May 04, 2025

Key Highlights

  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2584 as of 02 May 15:30.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 25.6 on March 2020 to 34.7 on March 2024 . This represents a CAGR of 6.27% over 5 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 11921 crore on March 2020 to ₹ 28181 crore on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 1065 crore on March 2020 to ₹ 3439 crore on March 2024 . This represents a CAGR of 26.41% over 5 years.
  • The revenue of Ajanta Pharma Ltd for the Mar '25 is ₹ 1188 crore as compare to the Dec '24 revenue of ₹ 1176 crore. This represent the growth of 1.02% The revenue of Unichem Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 546.71 crore. This represent the decline of -100%.
  • The ebitda of Ajanta Pharma Ltd for the Mar '25 is ₹ 315.26 crore as compare to the Dec '24 ebitda of ₹ 351.27 crore. This represent the decline of -10.25% The ebitda of Unichem Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 99.14 crore. This represent the decline of -100%.
  • The net profit of Ajanta Pharma Ltd changed from ₹ 208.12 crore to ₹ 225.26 crore over 8 quarters. This represents a CAGR of 4.04% The net profit of Unichem Laboratories Ltd changed from ₹ -0.67 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Ajanta Pharma Ltd changed from 25.99 % on March 2020 to 79.83 % on March 2024 . This represents a CAGR of 25.16% over 5 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from -50 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About Unichem Laboratories Ltd

  • Unichem Laboratories Limited is an India-based pharmaceutical company, which manufactures active pharmaceutical ingredients.
  • The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
  • The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
  • The Baddi plant was approved by UK MHRA and MCC (South Africa).
  • The company received ISO 9001:2000 for all their plants and corporate office.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma to discuss results

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 April 202...

Read more

22 Apr 2025 17:19

News

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786...

Read more

03 Feb 2025 13:00

News

Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2...

Read more

17 Jan 2025 21:11

News

Ajanta Pharma Ltd slips for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2...

Read more

26 Dec 2024 13:35

News

Ajanta Pharma Ltd soars 1.25%, up for fifth straight session

Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 29...

Read more

22 Nov 2024 13:00

News

Ajanta Pharma Ltd gains for third straight session

Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 292...

Read more

19 Nov 2024 13:05

Unichem Laboratories Ltd News Hub

News

Unichem Laboratories receives upgrade in credit ratings from ICRA

Unichem Laboratories announced that t ICRA, the credit rating agency has upgraded the rati...

Read more

18 Feb 2025 19:58

News

Unichem Laboratories schedules board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 6 Feb...

Read more

14 Jan 2025 14:54

News

Unichem Laboratories to discuss results

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 13 No...

Read more

25 Oct 2024 16:49

News

Unichem Laboratories to hold board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 30 Se...

Read more

23 Sep 2024 10:11

News

Board of Unichem Laboratories to consider proposal for consolidation of generic formulations biz in US

The Board of Unichem Laboratories will meet on 30 September 2024 to consider and approve i...

Read more

23 Sep 2024 09:45

News

Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity

In an exchange filing made before market hours today, the company said that its board will...

Read more

23 Sep 2024 09:26

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Unichem Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Unichem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ajanta Pharma Ltd and Unichem Laboratories Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or Unichem Laboratories Ltd?

Market cap of Ajanta Pharma Ltd is 32,281 Cr while Market cap of Unichem Laboratories Ltd is 4,144 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and Unichem Laboratories Ltd?

The stock performance of Ajanta Pharma Ltd and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and Unichem Laboratories Ltd?

As of May 4, 2025, the Ajanta Pharma Ltd stock price is INR ₹2584.35. On the other hand, Unichem Laboratories Ltd stock price is INR ₹588.6.

How do dividend payouts of Ajanta Pharma Ltd and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions